Company Profile
Myeloid Therapeutics
Company Overview
Myeloid Therapeutics is an immuno-oncology company developing its propriety ATAK myeloid cell program to cure cancer. ATAK cells are autologous myeloid cells that have been engineered to unleash their power to cure cancer. The platform technology has the opportunity to be applied broadly to numerous oncological conditions.
The company, having operations in Cambridge, MA, was founded by Ronald Vale and Siddhartha Mukherjee, and is funded by Newpath Partners.